MY105000A - New use of 5-heteroaryl-or-5-arly- substituted imidazo (2,1-a) isoquinolines - Google Patents

New use of 5-heteroaryl-or-5-arly- substituted imidazo (2,1-a) isoquinolines

Info

Publication number
MY105000A
MY105000A MYPI89001030A MYPI19891030A MY105000A MY 105000 A MY105000 A MY 105000A MY PI89001030 A MYPI89001030 A MY PI89001030A MY PI19891030 A MYPI19891030 A MY PI19891030A MY 105000 A MY105000 A MY 105000A
Authority
MY
Malaysia
Prior art keywords
arly
isoquinolines
heteroaryl
new use
substituted imidazo
Prior art date
Application number
MYPI89001030A
Inventor
Joseph Houlihan William
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/302,720 external-priority patent/US4910206A/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY105000A publication Critical patent/MY105000A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOUNDS OF FORMULA I(FORMULA 1)WHEREIN THE SUBSTITUENTS HAVE VARIOUS SIGNIFICANCES, ARE INDICATED FOR USE IN CONTROLLING HYPERREACTIVE AIRWAYS INDUCED BY PAF OR ALLERGEN AND IN THE PROPHYLACTIC TREATMENT OF ASTHMA. A PREFERRED ROUTE OF ADMINISTRATION IS BY INHALATION.
MYPI89001030A 1988-07-29 1989-07-28 New use of 5-heteroaryl-or-5-arly- substituted imidazo (2,1-a) isoquinolines MY105000A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22630488A 1988-07-29 1988-07-29
US07/302,720 US4910206A (en) 1986-07-14 1989-01-27 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Publications (1)

Publication Number Publication Date
MY105000A true MY105000A (en) 1994-07-30

Family

ID=79553788

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89001030A MY105000A (en) 1988-07-29 1989-07-28 New use of 5-heteroaryl-or-5-arly- substituted imidazo (2,1-a) isoquinolines

Country Status (1)

Country Link
MY (1) MY105000A (en)

Similar Documents

Publication Publication Date Title
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
MY111201A (en) New imidazopyridines
MY131458A (en) Pyrolopyrimidine compounds
GR3036675T3 (en) Piperazino derivatives as neurokinin antagonists
SE8801807D0 (en) NEW BENZO (B) PYRANES AND PYRANOPYRIDINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
GR3033034T3 (en) Novel pyrazine carboxamide derivatives, their production and their use in medicaments
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
IL125534A0 (en) A unit dose of budesonide and use thereof for nasal administration
EP0357550A3 (en) New use of 5-heteroaryl- or 5-aryl-substituted imidazo [2,1-a] isoquinolines
MY103963A (en) Isoquinoline derivatives, their preparation and their use
ES8501362A1 (en) Phthalazine substituted aminomethyl benzene derivatives, compositions and use.
EP0194161A3 (en) Cyclopentaûd¨pyrimidine derivatives, their preparation and use
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
MX9708416A (en) Piperazino derivatives as neurokinin antagonists.
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
TW259791B (en)
MY103216A (en) Nedocromil calcium and use thereof in treatment of reversible obstuctive airways disease
CA2084082A1 (en) 1-pyperidinyl alkanoylarysulfonamide derivatives
PH21295A (en) Octahydroindolizine compounds useful as analgesics
NZ219052A (en) Octahydroindolizine derivatives and pharmaceutical compositions
GB2069487B (en) Piperazine derivatives of theophylline
EP0784973A3 (en) Quinoxaline derivatives for treating tinnitus
MY103748A (en) A new antitumor agent obtained by microbial stereoselective reduction of 4-deoxy-4-iododoxorubicin